Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-03-01 Option Award | 2021-03-03 8:00 pm | N/A 2031-02-28 | Global Blood Therapeutics Inc. | GBT | CATHERS BRIAN EDWIN Chief Scientific Officer | 48,815 | $0 | 75,820 (Direct) | View |
| 2021-03-01 Exercise | 2021-03-03 8:00 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | CATHERS BRIAN EDWIN Chief Scientific Officer | 3,750 | $0 | 75,820 (Direct) | View |
| 2021-03-01 Tax Withholding | 2021-03-03 8:00 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | CATHERS BRIAN EDWIN Chief Scientific Officer | 1,297 | $44.48 | 75,820 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-03 6:28 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | CATHERS BRIAN EDWIN Chief Scientific Officer | 3,020 | $0 | 27,672 (Direct) | View |
| 2021-02-01 Tax Withholding | 2021-02-03 6:28 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | CATHERS BRIAN EDWIN Chief Scientific Officer | 1,178 | $49.49 | 27,672 (Direct) | View |
| 2021-02-01 Option Award | 2021-02-03 6:28 pm | N/A N/A | Global Blood Therapeutics Inc. | GBT | CATHERS BRIAN EDWIN Chief Scientific Officer | 267 | $41.17 | 27,672 (Direct) | View |